Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

US Patent 9127056 · Granted Sep 8, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) a2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
ADAM17 binding molecules and uses thereof2025
Protease cleavable bispecific antibodies and uses thereof2025
Protease cleavable bispecific antibodies and uses thereof2025
Virtual machine file management using file-level snapshots2025
Compositions and methods for treating cancer with anti-CD123 immunotherapy2024
Human monoclonal antibodies against EphA4 and their use2024
Methods of treatments using antigen-binding proteins targeting CD562024
Methods of treatments using antigen-binding proteins targeting CD562024
Human monoclonal antibodies specific for FLT3 and uses thereof2024
Human monoclonal antibodies specific for FLT3 and uses thereof2024